In addition, platelets in NAFLD seems to express the leptin receptor, a hormone which increased levels have been associated with a hypercoagulability state, arterial thrombosis and PVT development in non-cirrhotic NAFLD patients. The gene discussed is LEPR; the disease is metabolic dysfunction-associated steatotic liver disease.